Also found in: Dictionary.
See: difficult
Mentioned in ?
References in periodicals archive ?
Recurrent Clostridium difficile disease: epidemiology and clinical characteristics.
Clostridium difficile is a health problem that affects hundreds of thousands of patients and costs 10 billion dollars to 20 billion dollars every year in North America.
Clostridium difficile, a toxin-producing bacterium, spreads easily on the hands of caregivers and on hard surfaces such as bed rails, stethoscopes, and toilets.
difficile to find out whether they are circulating.
The University of North Tees had three MRSA deaths and 18 C Difficile deaths in the same period, says a report from the Office for National Statistics.
Now an MP has accused the Department Of Health (DoH) of "dramatically under-estimating" the real scale of Clostridium difficile, an infection more dangerous than MRSA.
Background: Apart from leukocytosis, few laboratory markers suggestive of Clostridium difficile infections have been described.
Clostridium difficile colitis is a major complication of antibiotic therapy.
Prof Brian Duerden, inspector of microbiology and infection control at the Department of Health, praised hospitals - as a new report was published stating healthcare trusts were not doing enough to prevent the spread of the infection clostridium difficile.
difficile cases went up by 65 last year, said: 'We have stringent cleanliness policies which include ensuring that patients who have symptoms of Clostridium difficile are nursed in isolation whenever possible, the handwashing protocol is adhered to and once the patient is clear of the infection, a full environmental disinfection is undertaken.
LOS ANGELES -- Discussion about the spread of a highly toxic new strain of Clostridium difficile dominated a recent meeting of infectious disease specialists and hospital epidemiologists, who cautioned that widespread reports of the aggressive nosocomial infection might be just the tip of the iceberg.
Acambis plc (Cambridge, England; 44-1223-275-300) has been issued with a broad patent in the US for its passive vaccine to treat Clostridium difficile ("C.